Opicapone capsules are a COMT inhibitor, primarily used as adjunctive therapy for Parkinson's disease. Their core function is to prolong the efficacy of levodopa and reduce symptom fluctuations caused by long-term medication use (such as the "wearing-off phenomenon"), thereby improving motor function and quality of life. It must be used under medical guidance, and the dosage should not be adjusted independently.

Detailed Explanation of Mechanisms and Efficacy

1. Mechanism of Action

By inhibiting catechol-O-methyltransferase (COMT), it reduces the peripheral metabolism of levodopa, allowing more of it to enter the brain to be converted into dopamine and enhancing therapeutic efficacy.

When used in combination with levodopa/carbidopa, it can prolong the half-life of levodopa, stabilize blood drug concentrations, and reduce symptom fluctuations.

2. Main Efficacy

Reduction of "on-off phenomena": Alleviating sudden loss of motor function ("OFF" periods) or recovery ("ON" periods) caused by drug concentration fluctuations in Parkinson's disease patients.

Prolonging effective treatment time: Making the therapeutic effect of levodopa more sustained and reducing the daily frequency of medication administration.

Improvement of motor symptoms: Such as rigidity, tremors, and bradykinesia.

3. Target Population

Mid-to-late-stage Parkinson's disease patients, especially those experiencing wearing-off effects or symptom fluctuations.

Must be used in combination with levodopa-class medications; it is ineffective when used alone.

4. Medication Precautions

Adjust dosage under medical guidance: The initial dose is typically 50 mg, taken with food to reduce gastrointestinal reactions, and subsequently adjusted based on therapeutic response.

Contraindications: Prohibited in patients with severe hepatic or renal impairment, or pheochromocytoma; concurrent use with non-selective MAO inhibitors may trigger a hypertensive crisis.

Side effect monitoring: Dyskinesia, nausea, and reddish/brownish discoloration of urine (a normal phenomenon) may occur; medical attention should be sought if symptoms are severe.

5. Long-term Management Recommendations

Regular follow-up visits to evaluate therapeutic efficacy and side effects; avoid abrupt discontinuation of medication, which can lead to worsening of symptoms.

Combine with comprehensive management such as rehabilitation training and dietary adjustments to enhance therapeutic outcomes.

This medication is a prescription drug and must be used strictly following a doctor's guidance. Abnormal reactions occurring during the medication period should be reported promptly to a physician.